Table 2.
HC | AD | LBD | Kruskal–Wallis | Post hoc tests | |||
---|---|---|---|---|---|---|---|
HC vs. AD | HC vs. LBD | AD vs. LBD | |||||
Mu | 649.43 (73.88) | 748.90 (139.38) | 930.73 (166.22) | F2 = 40.49, p < 0.001 | p = 0.06 | p < 0.001 | p < 0.001 |
Sigma | 59.85 (22.87) | 78.57 (46.98) | 125.03 (62.75) | F2 = 23.25, p < 0.001 | p = 0.88 | p < 0.001 | p = 0.001 |
Tau | 313.48 (119.50) | 523.28 (202.89) | 572.99 (213.21) | F2 = 24.16, p < 0.001 | p < 0.001 | p < 0.001 | p = 1.00 |
Between-group differences were assessed by Kruskal–Wallis ANOVA with Dunn’s post hoc tests, p values are Bonferroni-corrected for multiple comparisons
AD Alzheimer’s disease, HC healthy controls, LBD Lewy body dementia